Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Position statement on clinical evaluation of imaging AI.
McCague C, MacKay K, Welsh C, Constantinou A, Jena R, Crispin-Ortuzar M; Imaging AI evaluation consensus group. McCague C, et al. Among authors: crispin ortuzar m. Lancet Digit Health. 2023 Jul;5(7):e400-e402. doi: 10.1016/S2589-7500(23)00090-0. Lancet Digit Health. 2023. PMID: 37391263 Free article. No abstract available.
Introduction to radiomics for a clinical audience.
McCague C, Ramlee S, Reinius M, Selby I, Hulse D, Piyatissa P, Bura V, Crispin-Ortuzar M, Sala E, Woitek R. McCague C, et al. Among authors: crispin ortuzar m. Clin Radiol. 2023 Feb;78(2):83-98. doi: 10.1016/j.crad.2022.08.149. Clin Radiol. 2023. PMID: 36639175 Free article. Review.
Lesion-specific 3D-printed moulds for image-guided tissue multi-sampling of ovarian tumours: A prospective pilot study.
Delgado-Ortet M, Reinius MAV, McCague C, Bura V, Woitek R, Rundo L, Gill AB, Gehrung M, Ursprung S, Bolton H, Haldar K, Pathiraja P, Brenton JD, Crispin-Ortuzar M, Jimenez-Linan M, Escudero Sanchez L, Sala E. Delgado-Ortet M, et al. Among authors: crispin ortuzar m. Front Oncol. 2023 Feb 13;13:1085874. doi: 10.3389/fonc.2023.1085874. eCollection 2023. Front Oncol. 2023. PMID: 36860310 Free PMC article.
Integrating Artificial Intelligence Tools in the Clinical Research Setting: The Ovarian Cancer Use Case.
Escudero Sanchez L, Buddenkotte T, Al Sa'd M, McCague C, Darcy J, Rundo L, Samoshkin A, Graves MJ, Hollamby V, Browne P, Crispin-Ortuzar M, Woitek R, Sala E, Schönlieb CB, Doran SJ, Öktem O. Escudero Sanchez L, et al. Among authors: crispin ortuzar m. Diagnostics (Basel). 2023 Aug 30;13(17):2813. doi: 10.3390/diagnostics13172813. Diagnostics (Basel). 2023. PMID: 37685352 Free PMC article.
Deep learning-based segmentation of multisite disease in ovarian cancer.
Buddenkotte T, Rundo L, Woitek R, Escudero Sanchez L, Beer L, Crispin-Ortuzar M, Etmann C, Mukherjee S, Bura V, McCague C, Sahin H, Pintican R, Zerunian M, Allajbeu I, Singh N, Sahdev A, Havrilesky L, Cohn DE, Bateman NW, Conrads TP, Darcy KM, Maxwell GL, Freymann JB, Öktem O, Brenton JD, Sala E, Schönlieb CB. Buddenkotte T, et al. Among authors: crispin ortuzar m. Eur Radiol Exp. 2023 Dec 7;7(1):77. doi: 10.1186/s41747-023-00388-z. Eur Radiol Exp. 2023. PMID: 38057616 Free PMC article.
Integrated radiogenomics models predict response to neoadjuvant chemotherapy in high grade serous ovarian cancer.
Crispin-Ortuzar M, Woitek R, Reinius MAV, Moore E, Beer L, Bura V, Rundo L, McCague C, Ursprung S, Escudero Sanchez L, Martin-Gonzalez P, Mouliere F, Chandrananda D, Morris J, Goranova T, Piskorz AM, Singh N, Sahdev A, Pintican R, Zerunian M, Rosenfeld N, Addley H, Jimenez-Linan M, Markowetz F, Sala E, Brenton JD. Crispin-Ortuzar M, et al. Nat Commun. 2023 Oct 24;14(1):6756. doi: 10.1038/s41467-023-41820-7. Nat Commun. 2023. PMID: 37875466 Free PMC article.
Personalized, connected health enabled by AI and home-based diagnostics.
Ahmad SS, Meehan A, Crispin-Ortuzar M, Weckman NE. Ahmad SS, et al. Among authors: crispin ortuzar m. Trends Biotechnol. 2023 Jul;41(7):982-983. doi: 10.1016/j.tibtech.2023.03.013. Epub 2023 Jun 5. Trends Biotechnol. 2023. PMID: 37286449 No abstract available.
Clinically Interpretable Radiomics-Based Prediction of Histopathologic Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma.
Rundo L, Beer L, Escudero Sanchez L, Crispin-Ortuzar M, Reinius M, McCague C, Sahin H, Bura V, Pintican R, Zerunian M, Ursprung S, Allajbeu I, Addley H, Martin-Gonzalez P, Buddenkotte T, Singh N, Sahdev A, Funingana IG, Jimenez-Linan M, Markowetz F, Brenton JD, Sala E, Woitek R. Rundo L, et al. Among authors: crispin ortuzar m. Front Oncol. 2022 Jun 16;12:868265. doi: 10.3389/fonc.2022.868265. eCollection 2022. Front Oncol. 2022. PMID: 35785153 Free PMC article.
123 results